Crossref
AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma
Mediastinum · 2026-10 · 10 · AB003-AB003
DOI: 10.21037/med-26-ab003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediastinum, 2026-10. Verfasst von Zhiheng Yao und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yao, Z., Li, H., Yang, Z., Cai, Y., Zhong, L., Zhao, Z., Liu, W., Yu, W., Zheng, B., & Chen, C. (2026). AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma. Mediastinum, 10, AB003-AB003. https://doi.org/10.21037/med-26-ab003
Vancouver
Yao Z, Li H, Yang Z, Cai Y, Zhong L, Zhao Z, et al. AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma. Mediastinum. 2026;10:AB003-AB003. doi:10.21037/med-26-ab003
BibTeX
@article{Yao2026,
author = {Yao, Zhiheng and Li, Hongmu and Yang, Zhenyuan and Cai, Yiling and Zhong, Leqi and Zhao, Zhenyu and Liu, Weichen and Yu, Weixiong and Zheng, Bin and Chen, Chun},
title = {AB003. Adjuvant treatment pathways and disease control after R0 resection for thymic squamous cell carcinoma},
journal = {Mediastinum},
year = {2026},
volume = {10},
pages = {AB003--AB003},
doi = {10.21037/med-26-ab003}
}
EUVIMED